tiprankstipranks
Trending News
More News >
Novocure announces results from Phase 3 PANOVA-3 trial
PremiumThe FlyNovocure announces results from Phase 3 PANOVA-3 trial
6d ago
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
NovoCure’s Strong Financial Performance and Promising Pipeline Drive Buy Rating
1M ago
Novocure’s Q1 2025: Revenue Growth and Strategic Advances
Premium
Company Announcements
Novocure’s Q1 2025: Revenue Growth and Strategic Advances
1M ago
Novocure to present Phase 3 PANOVA-3 trial results at ASCO 2025
PremiumThe FlyNovocure to present Phase 3 PANOVA-3 trial results at ASCO 2025
2M ago
Novocure price target lowered to $34 from $42 at Piper Sandler
Premium
The Fly
Novocure price target lowered to $34 from $42 at Piper Sandler
2M ago
Novocure announces CE Mark for Optune Lua
Premium
The Fly
Novocure announces CE Mark for Optune Lua
2M ago
Novocure Reports Strong 2024 Revenue Growth
PremiumCompany AnnouncementsNovocure Reports Strong 2024 Revenue Growth
3M ago
NovoCure’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
NovoCure’s Earnings Call: Growth Amid Challenges
3M ago
Novocure reports Q4 EPS (61c), consensus (34c)
Premium
The Fly
Novocure reports Q4 EPS (61c), consensus (34c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100